記憶力增強藥物市場：依藥物類別、給藥途徑、適應症、通路及地區分類

據估計，2026年記憶增強藥物市值為98.236億美元，預計2033年將達到142.525億美元。預計從2026年到2033年，該市場將以5.5%的複合年成長率成長。

記憶增強藥物用於治療因老齡化或中樞神經系統（CNS）損傷導致的記憶障礙。阿茲海默症可能以記憶障礙或認知能力下降為首發症狀。雖然腦細胞因創傷（尤其是腦部創傷）而死亡很常見，但與老齡化相關的記憶障礙是一種正常現象，可以透過記憶增強藥物進行治療。

雖然獲得監管機構核准的記憶增強劑市場佔有率較低，但目前正在進行多項臨床試驗以檢驗其有效性。目前市面上大多數記憶增強劑都源自於膳食，含有維生素、抗氧化劑和脂質。世界各地的監管機構也正在核准新的記憶增強藥物用於醫療用途。利他能和Adderall是兩種仿單標示外用於記憶增強的例子。認知功能和記憶增強劑以及外用補充劑的目標是提高個體的認知能力，包括執行功能，例如動機、創造力和記憶力。這些藥物通常用於難以維持最佳認知功能的患者。它們也被用來幫助患有阿茲海默症、思覺失調症、妄想症和注意力缺陷障礙（ADD）等精神疾病的患者應對症狀。

市場動態

市場上的主要企業正致力於增加記憶增強藥物的臨床試驗數量。例如，根據2020年1月發表在《生物醫學科學期刊》（Journal of Biomed Science）上的報導，研究人員目前正在測試多種針對不同標靶的潛在療法，包括抗澱粉樣蛋白和抗Tau、神經傳導物質調節、抗神經發炎和神經保護、認知功能增強以及治療方法行為和心理症狀的治療方法。

本次調查的主要特點。

• 本報告對全球記憶增強藥物市場進行了詳細分析，以 2021 年為基準年，給出了預測期（2022-2030 年）的市場規模和復合年成長率 (CAGR%)。
• 本報告指出了各個細分市場的潛在商機，並說明了該市場中具有吸引力的投資提案矩陣。
• 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
• 本報告根據以下參數分析了全球記憶增強藥物市場的主要企業：公司概況、產品系列、主要亮點、財務表現和策略。
• 透過利用本報告中提出的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
• 本報告面向該產業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 透過利用全球記憶增強藥物市場分析中使用的各種策略矩陣，相關人員可以更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

• 研究目標
• 前提
• 簡稱

第2章 市場範圍

• 報告摘要
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 阻礙因素
  • 機會
• 影響分析
• 法規環境
• 市場趨勢
• 管道分析
• 主要進展
• 流行病學
• PEST分析

第4章 全球記憶增強藥物市場：依藥物類別分類，2026-2033年

• 膽鹼酯酶抑制劑
• 聰明藥/認知增強藥（益智藥）
• 維生素和補充劑
• 其他

第5章 全球記憶增強藥物市場：依給藥途徑分類，2026-2033年

• 口服
• 注射
• 外用

第6章 全球記憶增強藥物市場：依適應症分類，2026-2033年

• 疾病治療
• 運動能力
• 學業成績
• 其他

第7章 全球記憶增強藥物市場：依通路分類，2026-2033年

• 醫院藥房
• 零售藥房
• 網路藥房

第8章 全球記憶增強藥物市場：依地區分類，2026-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
• 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 亞太其他地區
• 中東
  • GCC
  • 以色列
  • 其他中東國家
• 非洲
  • 北非
  • 中非
  • 南非

第9章 競爭情勢

• 熱圖分析
• 市佔率分析
  • Pfizer Inc
  • UCB SA
  • Takeda Pharmaceutical Company
  • Shire plc.
  • Sanochemia Pharmazeutika AG
  • Allergan plc.
  • Novartis AG
  • . Alkem Laboratories Ltd
  • Paradigm Healthcare
  • Intas Pharmaceutical Ltd.,
  • Taurus Laboratories Pvt. Ltd.

第10章

• 調查方法
• 關於本公司

Memory Enhancement Drugs Market is estimated to be valued at USD 9,823.6 Mn in 2026 and is expected to reach USD 14,252.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.5% from 2026 to 2033.

Drugs that improve memory are used to treat people who have memory loss as a result of age or traumatic injury to the central nervous system (CNS). Alzheimer's disease may begin as a result of the onset of memory loss or a decline in cognition. Brain cells frequently die as a result of trauma, particularly to the brain, and although memory loss is normal as people age, it is treatable with medications that improve memory.

Despite the low market presence of regulatory authorities-approved memory-enhancing medications, several clinical trials are being conducted to examine the results. The majority of currently available medications that improve memory come from diet, such as vitamins, antioxidants, lipids, etc. Different countries of the world have also approved new medications that improve memory for medical use. Ritalin and Adderall are two examples of off-label medications that are being used as memory boosters. The goal of cognitive and memory enhancement medications and external supplements is to increase a person's cognitive capacity, which includes executive functions like motivation, creativity, and memory. These medications are prescribed to patients who have trouble sustaining their cognitive functions at their peak levels. These medications are used to treat patients with mental health conditions such Alzheimer's, schizophrenia, paranoia, and attention deficit disorder (ADD) in order to assist them cope with the ailment's symptoms.

Market Dynamics

Key players operating in the market are focused on increasing number of clinical trials for memory enhancement drugs. For instance, according to an article published in January 2020, on Journal of Biomed Science, researchers are currently testing a number of potential treatments with various targets, including anti-amyloid and anti-tau, neurotransmitter modification, anti-neuroinflammation and neuroprotection, cognitive enhancement, and treatments to relieve behavioral and psychological symptoms.

Key features of the study

• This report provides an in-depth analysis of the global memory enhancement drugs market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global memory enhancement drugs market based on the following parameters - Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies.
• Key companies covered as a part of this study Pfizer Inc., UCB S.A., Takeda Pharmaceutical Company, Shire plc. Sanochemia Pharmazeutika AG, Allergan plc., Novartis AG, Alkem Laboratories Ltd., Paradigm Healthcare, Intas Pharmaceutical Ltd., Taurus Laboratories Pvt. Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global memory enhancement drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global memory enhancement drugs market.

Market Segmentation

• Global Memory Enhancement Drugs Market, By Drug Class
  • Cholinesterase Inhibitors
  • Smart Drugs and Cognitive Enhancers (Nootropics)
  • Vitamins and Supplements
  • Others
• Global Memory Enhancement Drugs Market, By Route of Administration
  • Oral
  • Injectable
  • Topical
• Global Memory Enhancement Drugs Market, By Application
  • Disease treatment
  • Athletic performance
  • Academic performance
  • Others
• Global Memory Enhancement Drugs Market, By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
• Global Memory Enhancement Drugs Market, By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players
  • Pfizer Inc.
  • UCB S.A.
  • Takeda Pharmaceutical Company
  • Shire plc.
  • Sanochemia Pharmazeutika AG
  • Allergan plc.
  • Novartis AG
  • Alkem Laboratories Ltd.
  • Paradigm Healthcare
  • Intas Pharmaceutical Ltd.
  • Taurus Laboratories Pvt. Ltd.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Drug Class
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Application
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunity
• Impact Analysis
• Regulatory Scenario
• Market Trends
• Pipeline Analysis
• Key Developments
• Epidemiology
• PEST Analysis

4. Global Memory Enhancement Drugs Market, By Drug Class, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2030 (%)
  • Y-o-Y Growth Analysis, 2022 - 2030
  • Segment Trends
• Cholinesterase Inhibitors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Smart Drugs and Cognitive Enhancers (Nootropics)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Vitamins and Supplements
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

5. Global Memory Enhancement Drugs Market, By Route of administration, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2030 (%)
  • Y-o-Y Growth Analysis, 2022 - 2030
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Injectable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Topical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

6. Global Memory Enhancement Drugs Market, By Application, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2030 (%)
  • Y-o-Y Growth Analysis, 2022 - 2030
  • Segment Trends
• Disease treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Athletic performance
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Academic performance
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Others
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2026 - 2030
  • Segment Trends

7. Global Memory Enhancement Drugs Market, By Distribution Channel, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2030 (%)
  • Y-o-Y Growth Analysis, 2022 - 2030
  • Segment Trends
• Hospital Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Retail Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Online Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

8. Global Memory Enhancement Drugs Market, By Region, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2022-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Mn)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026-2033, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis
  • Pfizer Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • UCB S.A.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Takeda Pharmaceutical Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Shire plc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sanochemia Pharmazeutika AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Allergan plc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • . Alkem Laboratories Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Paradigm Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Intas Pharmaceutical Ltd.,
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Taurus Laboratories Pvt. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies

10. Section

• Research Methodology
• About us